BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16981185)

  • 1. An efficient test for the analysis of dichotomized variables when the reliability is known.
    Borm GF; Munneke M; Lemmers O; van Zuijlen M
    Stat Med; 2007 Aug; 26(18):3498-510. PubMed ID: 16981185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials and the response rate illusion.
    Kirsch I; Moncrieff J
    Contemp Clin Trials; 2007 Jul; 28(4):348-51. PubMed ID: 17182286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the statistical power of different methods for the analysis of cluster randomization trials with binary outcomes.
    Austin PC
    Stat Med; 2007 Aug; 26(19):3550-65. PubMed ID: 17238238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculation of sample size for stroke trials assessing functional outcome: comparison of binary and ordinal approaches.
    Optimising Analysis of Stroke Trials Collaboration
    Int J Stroke; 2008 May; 3(2):78-84. PubMed ID: 18705999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding clinical trial outcomes: design, analysis, and interpretation.
    Jacobe HT; Leitenberger JJ; Bergstresser PR
    Dermatol Ther; 2007; 20(2):77-85. PubMed ID: 17537135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robustness of an odds-ratio test in a stratified group sequential trial with a binary outcome measure.
    Srivastava DK; Rai SN; Pan J
    Biom J; 2007 Jun; 49(3):351-64. PubMed ID: 17623341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A permutation test for inference in logistic regression with small- and moderate-sized data sets.
    Potter DM
    Stat Med; 2005 Mar; 24(5):693-708. PubMed ID: 15515134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple method for calculating power based on a prior trial.
    Borm GF; Bloem BR; Munneke M; Teerenstra S
    J Clin Epidemiol; 2010 Sep; 63(9):992-7. PubMed ID: 20573484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Gould-Shih procedure for sample size re-estimation.
    Waksman JA
    Pharm Stat; 2007; 6(1):53-65. PubMed ID: 17133631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.
    Leon AC
    J Clin Psychiatry; 2004 Nov; 65(11):1511-4. PubMed ID: 15554764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates, power and sample size calculations for two-sample ordinal outcomes under before-after study designs.
    Strickland PA; Lu SE
    Stat Med; 2003 Jun; 22(11):1807-18. PubMed ID: 12754716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the limitations of statistical analysis of treatment outcomes used in periodontal research.
    Galgut PN
    J Int Acad Periodontol; 2003 Oct; 5(4):92-7. PubMed ID: 14604057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis and importance of statistical power and sample size in empirical scientific research].
    Klimek KM
    Wiad Lek; 2008; 61(7-9):211-5. PubMed ID: 19172834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining sample size and power in clinical trials: the forgotten essential.
    Grimes DA; Schulz KF
    Semin Reprod Endocrinol; 1996 May; 14(2):125-31. PubMed ID: 8796935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population enrichment designs: case study of a large multinational trial.
    Mehta CR; Gao P
    J Biopharm Stat; 2011 Jul; 21(4):831-45. PubMed ID: 21516572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of two-part models with competitors.
    Lachenbruch PA
    Stat Med; 2001 Apr; 20(8):1215-34. PubMed ID: 11304737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shifting our thinking about uncommon disease trials: the case of methotrexate in scleroderma.
    Johnson SR; Feldman BM; Pope JE; Tomlinson GA
    J Rheumatol; 2009 Feb; 36(2):323-9. PubMed ID: 19040308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How many repeated measurements are useful?
    Overall JE
    J Clin Psychol; 1996 May; 52(3):243-52. PubMed ID: 8835686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.